-
Mashup Score: 3The importance of nutrition in hematology and cancer care - 16 hour(s) ago
Shireen Kassam, MBBS, PhD, FRCPath, dipIBLM, Kingβs College London, London, UK, provides an insight into the importance of food and nutrition in medicine and highlights why it is a commonly overlooked tool in hematology and cancer care. Through nutritional and lifestyle changes, patients can reduce the burden of chronic conditions, which may affect their eligibility for various cancer treatments, and improve their quality of life and likelihood of survival during and after treatment. This interview took place at the 64th Annual Scientific Meeting of the British Society for Haematology (BSH) Congress in Liverpool, UK. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5VJHemOnc β The video journal of hematological oncology - 21 hour(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet-
#SOHO2023 is taking place next week in Houston, TX!π We @VJHemOnc are looking forward to interviewing and sharing the latest in #Leukemia, #Lymphoma and more. Follow us and check out https://t.co/O9p0vDBrzw to stay updated! @SocietyofHemOnc #LeuSM #LymSM #MMsm #MDSsm #MPNsm https://t.co/cQo18FkF3a
-
-
Mashup Score: 11Post-ASCO & EHA 2024 Highlights - 22 hour(s) ago
Webinar series by VJHemOnc featuring presentations & discussions on key abstracts in hematological malignancies presented at the ASCO & EHA 2024 meetings.
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet-
Join us for our Post-ASCO & EHA 2024 Highlights π£ π©Έ Featuring presentations & panel discussions on selected abstracts from #ASCO & #EHA 2024 π¦ REGISTER π https://t.co/K156Bqw85Z #EHA2024 #ASCO24 @harrisoncn1 @myelomaMD @Daver_Leukemia @AnnaSureda5 @DrMDavids @Dr_AmerZeidan https://t.co/5RxaWFSHs4
-
-
Mashup Score: 1Clinical trial updates in myeloma: managing bone disease, the use of isatuximab, belantamab mafodotin & more - 2 day(s) ago
In this fascinating discussion, Ola Landgren, MD, Sylvester Comprehensive Cancer Center, University of Miami, Miami, FL, Suzanne Lentzsch, MD, PhD, Columbia University, New York, NY, Thomas Martin, MD, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA, and Suzanne Trudel, MSc, MD, Princess Margaret Cancer Centre, Toronto, Canada, share updates with the use of various agents in multiple myeloma. First, Dr Lentzsch talks on the use of bisphosphonates to manage bone disease in myeloma. Following this, Dr Martin shares updates with the use of isatuximab, highlighting findings from the IsKia and IKEMA trials (NCT04483739; NCT03275285), and Dr Trudel shares updates with the use of belantamab mafodotin in myeloma. To conclude, the experts share their thoughts on the importance of using measurable residual disease (MRD) as an endpoint in clinical trials to accelerate the approval of agents for patients with myeloma. This session was filmed at the 17th International Worksh
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 2
Beverley Hunt, OBE, FRCP, FRCPath, Guy’s and St Thomas’ NHS Foundation Trust, London, UK, discusses her work on effective primary preventative strategies to reduce the risk of atherosclerotic events in patients with hemophilia as the life expectancy of individuals increases. Having hemophilia does not protect against atherosclerosis; therefore, Prof. Hunt suggests that hemophilia clinics must consider the modulation of diet and exercise and statin use for patients with hemophilia to reduce the risk of heart attack and stroke. This interview took place at the 64th Annual Scientific Meeting of the British Society for Haematology (BSH) Congress in Liverpool, UK. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 1Alberto Olaya-Vargas | Videos & Research | VJHemOnc - 3 day(s) ago
Alberto Olaya-Vargas speaks exclusively to VJHemOnc , The Video Journal of Hematological Oncology. Watch interviews and discussions with Alberto Olaya-Vargas here.
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 3MDS Sessions: Treating lower-risk MDS beyond ESA failure: novel agents & future outlooks | VJHemOnc - 3 day(s) ago
Welcome to The MDS Sessions brought to you by the Video Journal of Hematology and Hematological Oncology (VJHemOnc). This exclusive discussion features leading experts Amer Zeidan, Valeria Santini, and Courtney DiNardo, who discuss the treatment of LR-MDS following ESA failure. The experts provide insight into agents currently approved for use in clinical practice and those in late stages of testing in clinical trials, as well as sharing their outlooks on the future of treating patients in this setting.
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet-
Weβre delighted to share our latest MDS session, chaired by @Dr_AmerZeidan, ft. @Santin13Valeria, & Courtney DiNardo, who take a deep dive into the treatment of LR-MDS following ESA failure, discussing novel agents & future outlooks! πhttps://t.co/xmfo4jrwc7 #MDSsm #HemOnc https://t.co/PLniJVOA7G
-
-
Mashup Score: 5Promising therapeutic efficacy of EBV-specific T-cell immunotherapy tabelecleucel in PTLD - 3 day(s) ago
Nina Worel, MD, Medical University of Vienna, Vienna, Austria, discusses the efficacy of allogeneic Epstein-Barr virus (EBV)-specific T-cell immunotherapy, tabelecleucel, in patients with post-transplant lymphoproliferative disease (PTLD). Prof. Worel explains that tabelecleucel utilizes T-cells derived from third-party EBV-immune donors. She emphasizes the development of a tissue-specific T-cell library with various human leukocyte antigen (HLA) systems tailored to individual PTLD cases. Prof. Worel highlights tabelecleucel’s efficacy in treating PTLD with minimal severe adverse events (AEs). This interview took place at the 50th Annual Meeting of the EBMT in Glasgow, Scotland. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 4Increasing awareness of germline predispositions to hematological malignancies in pediatric patients - 4 day(s) ago
Anupama Rao, MD, Great Ormond Street Hospital, London, UK, highlights the necessity for increasing clinician awareness in regard to the presence of germline predispositions to hematological malignancies, such as acute myeloid leukemia (AML), in pediatric patients. Most hematological predispositions present as common conditions, and a national observational study for pediatric germline predisposition syndromes will aim to make clinicians aware that a proportion of their patients will have these predispositions. Clinicians will be encouraged to reach out to centers of expertise to create well-annotated cohorts of patients. This interview took place at the 64th Annual Scientific Meeting of the British Society for Haematology (BSH) Congress in Liverpool, UK. These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet
-
Mashup Score: 5VJHemOnc β The video journal of hematological oncology - 4 day(s) ago
The Video Journal of Hematological Oncology (VJHemOnc) is a global, open-access video journal, dedicated to providing trusted and up-to-date medical information in order to improve the awareness and understanding of hematological cancers
Source: www.vjhemonc.comCategories: General Medicine News, Onc News and JournalsTweet-
#SOHO2023 is taking place next week in Houston, TX!π We @VJHemOnc are looking forward to interviewing and sharing the latest in #Leukemia, #Lymphoma and more. Follow us and check out https://t.co/O9p0vDBrzw to stay updated! @SocietyofHemOnc #LeuSM #LymSM #MMsm #MDSsm #MPNsm https://t.co/cQo18FkF3a
-
The importance of nutrition in #Hematology and cancer care is often overlooked.ππ½οΈ In a recent interview, @shireenkassam1 (@KingsCollegeLon) comments on nutrition as a key tool when treating patients: π https://t.co/ryrEVVCJwN #HemOnc #SuppOnc #BSH2024 @BritSocHaem